← FDA Drug Approvals (Drugs@FDA)
REGORAFENIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL · Approved 2025-01-13
Drug application
- FDA Application #
ANDA209728- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- REGORAFENIB
- Generic name
- Regorafenib
- Active ingredients
- REGORAFENIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ACTAVIS LABS FL
- First approval
- 2025-01-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown